Denver Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Denver Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$354K	Hold	2,345	–	–	0.02%	355
2017 Q4	$316K	Hold	2,345	–	–	0.02%	374
2017 Q3	$343K	Hold	2,345	–	–	0.02%	360
2017 Q2	$365K	Hold	2,345	–	–	0.02%	362
2017 Q1	$340K	Hold	2,345	–	–	0.02%	381
2016 Q4	$256K	Sell	2,345 -5,275	-69%	-$588K	0.01%	423
2016 Q3	$926K	Sell	7,620 -22,390	-75%	-$3.02M	0.04%	269
2016 Q2	$4.24M	Buy	30,010 +19,440	+184%	+$2.87M	0.19%	140
2016 Q1	$1.38M	Buy	+10,570	New	+$1.32M	0.06%	237

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Denver Investment Advisors's JAZZ Position: Q1 2018 in Review

Denver Investment Advisors held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2018 at 2,345 shares worth $354K. The position accounts for 0.02% of the portfolio, ranked #355.

Denver Investment Advisors first reported a position in JAZZ in Q1 2016 and has held it in 9 quarters since. The position peaked at $4.24M in Q2 2016. 323 funds tracked by Wall St. Rank hold JAZZ as of Q1 2018.

Denver Investment Advisors held 2,345 shares of Jazz Pharmaceuticals worth $354K as of Q1 2018.
Denver Investment Advisors left its Jazz Pharmaceuticals share count unchanged in Q1 2018.
Jazz Pharmaceuticals made up 0.02% of Denver Investment Advisors's portfolio in Q1 2018, its #355 holding.
Denver Investment Advisors first reported a position in Jazz Pharmaceuticals in Q1 2016 and has held it in 9 quarters since.
Denver Investment Advisors's Jazz Pharmaceuticals position peaked at $4.24M in Q2 2016.
323 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.